Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iqvia Holdings Inc
(NY:
IQV
)
251.55
+0.76 (+0.30%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iqvia Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
April 23, 2024
From
IQVIA
Via
Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
April 15, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
April 09, 2024
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement.
Via
Benzinga
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
April 08, 2024
From
IQVIA
Via
Business Wire
Peering Into IQVIA Hldgs's Recent Short Interest
March 29, 2024
Via
Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
March 13, 2024
Via
Benzinga
How Is The Market Feeling About IQVIA Hldgs?
February 15, 2024
Via
Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
March 06, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Publishes its 2023 Environmental, Social and Governance Report
February 26, 2024
From
IQVIA
Via
Business Wire
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
February 23, 2024
From
IQVIA
Via
Business Wire
Earnings Scheduled For February 14, 2024
February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Via
Benzinga
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights
February 13, 2024
Via
Benzinga
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
February 21, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
February 14, 2024
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment
February 14, 2024
IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook.
Via
Benzinga
Expert Ratings For IQVIA Hldgs
January 25, 2024
Via
Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
January 08, 2024
Via
Benzinga
IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
January 04, 2024
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
December 22, 2023
Via
Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
February 14, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
February 14, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year
February 06, 2024
From
IQVIA
Via
Business Wire
How Is The Market Feeling About IQVIA Hldgs?
December 18, 2023
Via
Benzinga
$1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth This Much Today
December 14, 2023
Via
Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
December 11, 2023
Via
Benzinga
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
January 24, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report
January 17, 2024
From
IQVIA
Via
Business Wire
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.
Via
InvestorPlace
IQVIA's Bold Merger Move Blocked As FTC's Concerns Over Competition Take Center Stage
January 02, 2024
IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.